 | • レポートコード：MRC2-11QY12315 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫血液学のグローバル市場について調査・分析したレポートです。種類別（免疫血液分析装置・システム、免疫血液試薬）市場規模、用途別（血液関連疾患、HIV、肝炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫血液学の競争状況、市場シェア ・世界の免疫血液学市場：種類別市場規模 2015年-2020年（免疫血液分析装置・システム、免疫血液試薬） ・世界の免疫血液学市場：種類別市場規模予測 2021年-2026年（免疫血液分析装置・システム、免疫血液試薬） ・世界の免疫血液学市場：用途別市場規模 2015年-2020年（血液関連疾患、HIV、肝炎） ・世界の免疫血液学市場：用途別市場規模予測 2021年-2026年（血液関連疾患、HIV、肝炎） ・北米の免疫血液学市場分析：米国、カナダ ・ヨーロッパの免疫血液学市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫血液学市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫血液学市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫血液学市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bio-Rad Laboratories、Grifols、Immucor、Ortho Clinical Diagnostic、BD、Beckman Coulter、DIAGAST、Hemo bioscience、Institut de Biotechnologies Jacques Boy、MTC INVITRO、Seqirus、Tulip Group ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immunohematology assists in the screening of blood antigens, Rh factor, plasma, and white blood cell components in the donor blood. It is commonly known as blood banking, which deals with preparation of blood components for transfusion. It aids in reduction of transfusion-related fatalities, such as HIV and thalassemia.
Rising awareness among people in developed as well as developing countries is expected to drive the global immunohematology market in the near future. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. The Asia Pacific region has witnessed gradual adoption of new immunohematology technologies, increasing health care expenditure, and changing dynamics of the in vitro diagnostics industry in the region.
Market Analysis and Insights: Global Immunohematology Market
The global Immunohematology market size is projected to reach US$ 1418.8 million by 2026, from US$ 1368 million in 2020, at a CAGR of 3.4%% during 2021-2026.
Global Immunohematology Scope and Market Size
Immunohematology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunohematology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bio-Rad Laboratories
Grifols
Immucor
Ortho Clinical Diagnostic
BD
Beckman Coulter
DIAGAST
Hemo bioscience
Institut de Biotechnologies Jacques Boy
MTC INVITRO
Seqirus
Tulip Group
Market segment by Type, the product can be split into
Immunohematology Analyzers and Systems
Immunohematology Reagent
Market segment by Application, split into
Blood-Related Diseases
HIV
Hepatitis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunohematology Revenue
1.4 Market by Type
1.4.1 Global Immunohematology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunohematology Analyzers and Systems
1.4.3 Immunohematology Reagent
1.5 Market by Application
1.5.1 Global Immunohematology Market Share by Application: 2020 VS 2026
1.5.2 Blood-Related Diseases
1.5.3 HIV
1.5.4 Hepatitis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Immunohematology Market Perspective (2015-2026)
2.2 Global Immunohematology Growth Trends by Regions
2.2.1 Immunohematology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunohematology Historic Market Share by Regions (2015-2020)
2.2.3 Immunohematology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immunohematology Market Growth Strategy
2.3.6 Primary Interviews with Key Immunohematology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immunohematology Players by Market Size
3.1.1 Global Top Immunohematology Players by Revenue (2015-2020)
3.1.2 Global Immunohematology Revenue Market Share by Players (2015-2020)
3.1.3 Global Immunohematology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immunohematology Market Concentration Ratio
3.2.1 Global Immunohematology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immunohematology Revenue in 2019
3.3 Immunohematology Key Players Head office and Area Served
3.4 Key Players Immunohematology Product Solution and Service
3.5 Date of Enter into Immunohematology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunohematology Historic Market Size by Type (2015-2020)
4.2 Global Immunohematology Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Immunohematology Market Size by Application (2015-2020)
5.2 Global Immunohematology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immunohematology Market Size (2015-2020)
6.2 Immunohematology Key Players in North America (2019-2020)
6.3 North America Immunohematology Market Size by Type (2015-2020)
6.4 North America Immunohematology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immunohematology Market Size (2015-2020)
7.2 Immunohematology Key Players in Europe (2019-2020)
7.3 Europe Immunohematology Market Size by Type (2015-2020)
7.4 Europe Immunohematology Market Size by Application (2015-2020)
8 China
8.1 China Immunohematology Market Size (2015-2020)
8.2 Immunohematology Key Players in China (2019-2020)
8.3 China Immunohematology Market Size by Type (2015-2020)
8.4 China Immunohematology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immunohematology Market Size (2015-2020)
9.2 Immunohematology Key Players in Japan (2019-2020)
9.3 Japan Immunohematology Market Size by Type (2015-2020)
9.4 Japan Immunohematology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immunohematology Market Size (2015-2020)
10.2 Immunohematology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immunohematology Market Size by Type (2015-2020)
10.4 Southeast Asia Immunohematology Market Size by Application (2015-2020)
11 India
11.1 India Immunohematology Market Size (2015-2020)
11.2 Immunohematology Key Players in India (2019-2020)
11.3 India Immunohematology Market Size by Type (2015-2020)
11.4 India Immunohematology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immunohematology Market Size (2015-2020)
12.2 Immunohematology Key Players in Central & South America (2019-2020)
12.3 Central & South America Immunohematology Market Size by Type (2015-2020)
12.4 Central & South America Immunohematology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bio-Rad Laboratories
13.1.1 Bio-Rad Laboratories Company Details
13.1.2 Bio-Rad Laboratories Business Overview
13.1.3 Bio-Rad Laboratories Immunohematology Introduction
13.1.4 Bio-Rad Laboratories Revenue in Immunohematology Business (2015-2020))
13.1.5 Bio-Rad Laboratories Recent Development
13.2 Grifols
13.2.1 Grifols Company Details
13.2.2 Grifols Business Overview
13.2.3 Grifols Immunohematology Introduction
13.2.4 Grifols Revenue in Immunohematology Business (2015-2020)
13.2.5 Grifols Recent Development
13.3 Immucor
13.3.1 Immucor Company Details
13.3.2 Immucor Business Overview
13.3.3 Immucor Immunohematology Introduction
13.3.4 Immucor Revenue in Immunohematology Business (2015-2020)
13.3.5 Immucor Recent Development
13.4 Ortho Clinical Diagnostic
13.4.1 Ortho Clinical Diagnostic Company Details
13.4.2 Ortho Clinical Diagnostic Business Overview
13.4.3 Ortho Clinical Diagnostic Immunohematology Introduction
13.4.4 Ortho Clinical Diagnostic Revenue in Immunohematology Business (2015-2020)
13.4.5 Ortho Clinical Diagnostic Recent Development
13.5 BD
13.5.1 BD Company Details
13.5.2 BD Business Overview
13.5.3 BD Immunohematology Introduction
13.5.4 BD Revenue in Immunohematology Business (2015-2020)
13.5.5 BD Recent Development
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Details
13.6.2 Beckman Coulter Business Overview
13.6.3 Beckman Coulter Immunohematology Introduction
13.6.4 Beckman Coulter Revenue in Immunohematology Business (2015-2020)
13.6.5 Beckman Coulter Recent Development
13.7 DIAGAST
13.7.1 DIAGAST Company Details
13.7.2 DIAGAST Business Overview
13.7.3 DIAGAST Immunohematology Introduction
13.7.4 DIAGAST Revenue in Immunohematology Business (2015-2020)
13.7.5 DIAGAST Recent Development
13.8 Hemo bioscience
13.8.1 Hemo bioscience Company Details
13.8.2 Hemo bioscience Business Overview
13.8.3 Hemo bioscience Immunohematology Introduction
13.8.4 Hemo bioscience Revenue in Immunohematology Business (2015-2020)
13.8.5 Hemo bioscience Recent Development
13.9 Institut de Biotechnologies Jacques Boy
13.9.1 Institut de Biotechnologies Jacques Boy Company Details
13.9.2 Institut de Biotechnologies Jacques Boy Business Overview
13.9.3 Institut de Biotechnologies Jacques Boy Immunohematology Introduction
13.9.4 Institut de Biotechnologies Jacques Boy Revenue in Immunohematology Business (2015-2020)
13.9.5 Institut de Biotechnologies Jacques Boy Recent Development
13.10 MTC INVITRO
13.10.1 MTC INVITRO Company Details
13.10.2 MTC INVITRO Business Overview
13.10.3 MTC INVITRO Immunohematology Introduction
13.10.4 MTC INVITRO Revenue in Immunohematology Business (2015-2020)
13.10.5 MTC INVITRO Recent Development
13.11 Seqirus
10.11.1 Seqirus Company Details
10.11.2 Seqirus Business Overview
10.11.3 Seqirus Immunohematology Introduction
10.11.4 Seqirus Revenue in Immunohematology Business (2015-2020)
10.11.5 Seqirus Recent Development
13.12 Tulip Group
10.12.1 Tulip Group Company Details
10.12.2 Tulip Group Business Overview
10.12.3 Tulip Group Immunohematology Introduction
10.12.4 Tulip Group Revenue in Immunohematology Business (2015-2020)
10.12.5 Tulip Group Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Immunohematology Key Market Segments
Table 2. Key Players Covered: Ranking by Immunohematology Revenue
Table 3. Ranking of Global Top Immunohematology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immunohematology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunohematology Analyzers and Systems
Table 6. Key Players of Immunohematology Reagent
Table 7. Global Immunohematology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Immunohematology Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Immunohematology Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Immunohematology Market Share by Regions (2015-2020)
Table 11. Global Immunohematology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Immunohematology Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Immunohematology Market Growth Strategy
Table 17. Main Points Interviewed from Key Immunohematology Players
Table 18. Global Immunohematology Revenue by Players (2015-2020) (Million US$)
Table 19. Global Immunohematology Market Share by Players (2015-2020)
Table 20. Global Top Immunohematology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunohematology as of 2019)
Table 21. Global Immunohematology by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immunohematology Product Solution and Service
Table 24. Date of Enter into Immunohematology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 27. Global Immunohematology Market Size Share by Type (2015-2020)
Table 28. Global Immunohematology Revenue Market Share by Type (2021-2026)
Table 29. Global Immunohematology Market Size Share by Application (2015-2020)
Table 30. Global Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 31. Global Immunohematology Market Size Share by Application (2021-2026)
Table 32. North America Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Immunohematology Market Share (2019-2020)
Table 34. North America Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 35. North America Immunohematology Market Share by Type (2015-2020)
Table 36. North America Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 37. North America Immunohematology Market Share by Application (2015-2020)
Table 38. Europe Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Immunohematology Market Share (2019-2020)
Table 40. Europe Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Immunohematology Market Share by Type (2015-2020)
Table 42. Europe Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Immunohematology Market Share by Application (2015-2020)
Table 44. China Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 45. China Key Players Immunohematology Market Share (2019-2020)
Table 46. China Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 47. China Immunohematology Market Share by Type (2015-2020)
Table 48. China Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 49. China Immunohematology Market Share by Application (2015-2020)
Table 50. Japan Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Immunohematology Market Share (2019-2020)
Table 52. Japan Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Immunohematology Market Share by Type (2015-2020)
Table 54. Japan Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Immunohematology Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Immunohematology Market Share (2019-2020)
Table 58. Southeast Asia Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Immunohematology Market Share by Type (2015-2020)
Table 60. Southeast Asia Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Immunohematology Market Share by Application (2015-2020)
Table 62. India Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 63. India Key Players Immunohematology Market Share (2019-2020)
Table 64. India Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 65. India Immunohematology Market Share by Type (2015-2020)
Table 66. India Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 67. India Immunohematology Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Immunohematology Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Immunohematology Market Share (2019-2020)
Table 70. Central & South America Immunohematology Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Immunohematology Market Share by Type (2015-2020)
Table 72. Central & South America Immunohematology Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Immunohematology Market Share by Application (2015-2020)
Table 74. Bio-Rad Laboratories Company Details
Table 75. Bio-Rad Laboratories Business Overview
Table 76. Bio-Rad Laboratories Product
Table 77. Bio-Rad Laboratories Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 78. Bio-Rad Laboratories Recent Development
Table 79. Grifols Company Details
Table 80. Grifols Business Overview
Table 81. Grifols Product
Table 82. Grifols Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 83. Grifols Recent Development
Table 84. Immucor Company Details
Table 85. Immucor Business Overview
Table 86. Immucor Product
Table 87. Immucor Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 88. Immucor Recent Development
Table 89. Ortho Clinical Diagnostic Company Details
Table 90. Ortho Clinical Diagnostic Business Overview
Table 91. Ortho Clinical Diagnostic Product
Table 92. Ortho Clinical Diagnostic Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 93. Ortho Clinical Diagnostic Recent Development
Table 94. BD Company Details
Table 95. BD Business Overview
Table 96. BD Product
Table 97. BD Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 98. BD Recent Development
Table 99. Beckman Coulter Company Details
Table 100. Beckman Coulter Business Overview
Table 101. Beckman Coulter Product
Table 102. Beckman Coulter Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 103. Beckman Coulter Recent Development
Table 104. DIAGAST Company Details
Table 105. DIAGAST Business Overview
Table 106. DIAGAST Product
Table 107. DIAGAST Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 108. DIAGAST Recent Development
Table 109. Hemo bioscience Business Overview
Table 110. Hemo bioscience Product
Table 111. Hemo bioscience Company Details
Table 112. Hemo bioscience Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 113. Hemo bioscience Recent Development
Table 114. Institut de Biotechnologies Jacques Boy Company Details
Table 115. Institut de Biotechnologies Jacques Boy Business Overview
Table 116. Institut de Biotechnologies Jacques Boy Product
Table 117. Institut de Biotechnologies Jacques Boy Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 118. Institut de Biotechnologies Jacques Boy Recent Development
Table 119. MTC INVITRO Company Details
Table 120. MTC INVITRO Business Overview
Table 121. MTC INVITRO Product
Table 122. MTC INVITRO Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 123. MTC INVITRO Recent Development
Table 124. Seqirus Company Details
Table 125. Seqirus Business Overview
Table 126. Seqirus Product
Table 127. Seqirus Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 128. Seqirus Recent Development
Table 129. Tulip Group Company Details
Table 130. Tulip Group Business Overview
Table 131. Tulip Group Product
Table 132. Tulip Group Revenue in Immunohematology Business (2015-2020) (Million US$)
Table 133. Tulip Group Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunohematology Market Share by Type: 2020 VS 2026
Figure 2. Immunohematology Analyzers and Systems Features
Figure 3. Immunohematology Reagent Features
Figure 4. Global Immunohematology Market Share by Application: 2020 VS 2026
Figure 5. Blood-Related Diseases Case Studies
Figure 6. HIV Case Studies
Figure 7. Hepatitis Case Studies
Figure 8. Immunohematology Report Years Considered
Figure 9. Global Immunohematology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Immunohematology Market Share by Regions: 2020 VS 2026
Figure 11. Global Immunohematology Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Immunohematology Market Share by Players in 2019
Figure 14. Global Top Immunohematology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunohematology as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Immunohematology Revenue in 2019
Figure 16. North America Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Immunohematology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
後天性孤児造血疾患治療薬の世界市場（～2026年） Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …- 肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- 肝炎診断検査の世界市場（～2026年） Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period.…
- 肝炎検査ソリューションの世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- B型肝炎ウイルス（HBV）の世界市場（～2026年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…